宫颈液基细胞学检查2878例结果回顾性分析  

Retrospective Analysis on 2878 Cases of Cervical Thinprep Cytological Test

作　　者：张雁瑞[1] 黄新翼[1] 粱冠男[1] 陈莹莹[1] 卢翔宇[1] 

机构地区：[1]南方医科大学附属深圳市妇幼保健院病理科,深圳518028

出　　处：《中国医药导刊》2012年第6期1066-1067,共2页Chinese Journal of Medicinal Guide

摘　　要：目的:探讨宫颈液基细胞学(TCT)在宫颈病变筛查中的临床价值。方法:对2 878位妇女进行TCT检查,诊断结果阳性者行阴道镜检查并送病理活检,以病理组织学诊断结果为金标准进行比较分析。结果:2 878位妇女中,TCT检查发现异常者198例,检出率6.88%。其中ASC-US有155例;ASC-H有3例;LSIL有33例;HSIL有6例;AG-US有1例。TCT结果为ASC-H及以上的阳性病例与宫颈活检诊断结果的总符合率为87.5%,其中LSIL符合率为84.8%;ASC-H、HSIL及AG-US符合率均为100%。结论:宫颈液基细胞学检查结合TBS报告系统是一种有效的宫颈病变筛查方法。Objective：Discuss the clinical value of thinprep cytological test in diagnosis of early cervical disease.Methods：The positive of 2878 patients with thinprep cytological test were compared with routine colposcopic biopsy on histological diagnosis.Results：The positive patients were 198（6.88%）,ASCUS 155 cases,ASC-H 3 cases,LSIL 33 cases,HSIL 6cases and AG-US 1case.TCT and pathological results of the overall conformity rate was 87.5%.The conformity rate of LSIL was 84.8%,and ASC-H、HSIL and AG-US was 100%.Conclusion：The thinprep cytological test can effectively reflect the cervical lesions combined with the TBS testing system.

关 键 词：液基薄层细胞学 TBS报告系统 宫颈病变 

分 类 号：R737.33[医药卫生—肿瘤]